logo

For the Inventor, By the Inventor

Rockville Centre, NY, United States of America

John R Stephenson

USPTO Granted Patents = 15

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 356(Granted Patents)


Location History:

  • Rockville Center, NY (US) (2000 - 2001)
  • Santa Cruz, CA (US) (1996 - 2003)
  • Rockville Centre, NY (US) (1997 - 2003)

Company Filing History:

goldMedal9 out of 118 
 
Osi Pharmaceuticals, Inc.
 patents
silverMedal6 out of 16 
 
Oncogene Science, Inc.
 patents

Years Active: 1996-2003

Loading Chart...
15 patents (USPTO):Explore Patents
1. 6589733 - Methods of preparing compositions comprising chemicals capable of transcriptional modulators (2003-07-08),
2. 6586394 - Tissue-derived tumor growth inhibitor (2003-07-01),
3. 6559123 - Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof (2003-05-06),
4. 6425769 - Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof (2002-07-30),
5. 6376175 - Methods of discovering chemicals capable of functioning as gene expression modulators (2002-04-23),
6. 6203976 - Methods of preparing compositions comprising chemicals capable of transcriptional modulation (2001-03-20),
7. 6165712 - Methods of transcriptionally modulating expression of viral genes and (2000-12-26),
8. 6136779 - Methods of specifically transcriptionally modulating the expression of (2000-10-24),
9. 6083709 - Immunoassay for detection of mutant P53 polypeptide in serum (2000-07-04),
10. 5976793 - Methods of transcriptionally modulating gene expression and of (1999-11-02),
11. 5863733 - Methods of transcriptionally modulating gene expression and of (1999-01-26),
12. 5846720 - Methods of determining chemicals that modulate expression of genes (1998-12-08),
13. 5776502 - Methods of transcriptionally modulating gene expression (1998-07-07),
14. 5665543 - Method of discovering chemicals capable of functioning as gene (1997-09-09),
15. 5580722 - Methods of determining chemicals that modulate transcriptionally (1996-12-03),

Innovative Contributions of John R. Stephenson

Introduction

John R. Stephenson is an accomplished inventor based in Rockville Centre, NY, with a remarkable track record of 15 patents to his name. His innovative work primarily focuses on advancements in biotechnology and pharmaceuticals, showcasing the intersection of science and ingenuity.

Latest Patents

Among his most notable inventions, one patent details methods for preparing compositions comprising chemicals capable of transcriptional modulators. This method seeks to transcriptionally modulate the expression of genes associated with various physiological or pathological effects in multicellular organisms.

Another significant patent is related to a tissue-derived tumor growth inhibitor, which is a chromatographically recovered polypeptide identified by its specific amino acid sequence. This invention encompasses not only the polypeptide itself but also compositions and pharmaceutical applications aimed at inhibiting epithelial cell growth, healing wounds, and treating burns.

Career Highlights

Throughout his career, John R. Stephenson has made substantial contributions to the fields of biotechnology and pharmaceuticals while working with esteemed companies, including Osi Pharmaceuticals, Inc. and Oncogene Science, Inc. His work at these organizations has played a pivotal role in advancing medical research and product development.

Collaborations

John has had the opportunity to collaborate with notable scientists such as J. Gordon Foulkes and Christian Pieler. These collaborations have helped to foster innovation and enhance the impact of their collective research efforts.

Conclusion

John R. Stephenson exemplifies the spirit of innovation in the realm of biotechnology, with a legacy of patents that reflect his commitment to advancing medical science. His inventions not only demonstrate his expertise as an inventor but also contribute significantly to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…